Saving Lives Through Stem cell Extraction and Storage

Project Category: Registered charityProject Tags: Children & young people, Education, Jobs & Skills, Other and Vulnerable Society

  • Our Story

    MissionLeukaemia & Myeloma Research UK was founded in 2015 after one of the Trustees experienced a family bereavement. Our mission is to prevent people dying from blood cancer through prevention, research and more effective treatment. Blood cancer is the 3rd biggest cancer killer, claiming more lives than breast or prostate cancer each year.

     

    Our goal is to become the leading UK blood-cancer charity specialising in stem-cell therapy by: –

    • Actively supporting stem-cell research into blood cancers.
    • Raising awareness of stem-cell therapies.
    • Offer support and advice to blood cancer patients.
    • We want to protect those who are vulnerable to cancer through genetic predisposition by offering a free stem-cell storage service for qualifying families, which we call the Model Cell Biobank (MCB).

     

    Our Structure Leukaemia & Myeloma Research UK’s funding comes from a combination of donations, legacies and charitable activities. We actively promote and advertise funding events, such as a clothes recycling initiative; we provide fundraising materials; network with other like-minded organisations; and raise awareness around cancer treatments and support children with cancer by giving away free books to help them understand the disease (these are written by children for children). We are now appealing to Trusts and Foundations to support the funding for our innovative stem-cell project.

     

    Project – ‘Saving Lives Through Stem-Cell Extraction’ – We are seeking funding to pay for cord blood stem-cell storage for qualifying families who have a history of cancer, are in receipt of welfare or on a low income, and would therefore be unable to afford the cost of private bio-banking. The goal is to offer vulnerable families the opportunity to store their baby’s cord blood for twenty-five years, which will be available should the child or another member of the family require them. These cells are taken from the umbilical cord at the time of birth.

     

    Why the project is neededLeukaemia & Myeloma Research UK is developing the first free stem-cell storage (or MCB) service to promote ‘biological insurance’ – where a child’s cord-blood stem cells are stored at the time of birth, these can then be used by the child, or another family member, to treat disease. Stem cells are currently being used to treat over 80 diseases including leukaemia and bone-marrow cancers. Clinical trials are also ongoing to treat childhood diseases such as cerebral palsy, diabetes, Parkinson’s disease and even autism[1]. The MCB offers the life-saving option of a transplant for the child, or an immediate relative, and avoids the invasive, painful and expensive procedures of other stem-cell collection, such as bone marrow.

     

    Our work differs from the service offered by public banks, such as Anthony Nolan and the NHS Cord Blood Bank, in that the cord-blood stem cells are stored on behalf of the family and the service will be widely available throughout the UK. Currently, the public banks can only collect cord blood when the baby is born in one of ten hospitals (situated in Leicester, Manchester or in and around London), which is extremely limiting.

     

    Where private storage is offered in the UK, expectant parents must meet the full cost for the collection, processing and storage. Our service will be offered free of charge to any family claiming welfare and will be heavily subsidised for low income families. This expenditure includes the cost of the stem cell kits, the travelling to maternity wards by the phlebotomists, the cost of transporting the cord cells back to the bio-bank, and the cost of storage.

    Who it will help – The cord-blood banking service is available to qualifying expectant mothers who live in the UK. They must economically disadvantaged and be in receipt of Housing Benefit, Council Tax or Universal Credit, or on a low income and must meet the following criteria:

    • The stem cells will be used to treat the child, or another member of the family, for a medically attested treatment.
    • There is a history of cancer in the immediate family.

    In the long term this sort of preventative approach will not only save lives, but also save the NHS expenditure on medicinal treatments.

     

    Our Partnership – We have chosen Biovault Technical as the processing and storage facility for cord-stem cells. Biovault works in partnership with the NHS South West Peninsula Transplant Service, providing the processing and storage facility for peripheral blood and bone-marrow stem cells. This service can only be provided by JACIE-accredited bodies (Joint Accreditation Committee of the International Society for Cellular Therapy and the European Society for Blood and Marrow Transplants).

     

    Procedure – The cord-blood stem cells are stored on behalf of the participant for 25 years. The mother is the legal guardian of the cells until the child reaches the age of majority, at which point, ownership transfers to the child. After 25 years, the cells can be privately stored, donated for research, offered to a public bank, or destroyed. Consent from the child will be sought at this point and we would strongly encourage the donation of any remaining cells to public banks.

     

    What it will cost – Each extraction costs £3,196. We are aiming to reach two extractions per month. Any support towards this project would help us to reach out to more vulnerable families and children – for example a grant of £5,000 would help us to reach our target and save even more lives. Embryonic stem cells are undifferentiated, allowing them to be used in all parts of the body, giving them the potential to cure hundreds of diseases. They also reduce the need for animal testing.

    Although not our primary objective, we are aware of the huge potential of having a bank of stem cells which can be used to treat blood cancers, as well so many other diseases and illnesses. The longevity of these cells has proved they are as good 30 years later as on the day they were first extracted and stored. This alone offers huge potential for treatments and cures well into the future, saving the NHS money and resources.

    [1] See News section at: https://www.facebook.com/leukaemiamyelomaresearchuk.org/

  • Images
  • Map

    No Records Found

    Sorry, no records were found. Please adjust your search criteria and try again.

    Google Map Not Loaded

    Sorry, unable to load Google Maps API.

  • Social Feeds

    Owner verified listing

    Woodward Rd, Knowsley Industrial Park, Liverpool L33 7UY